MyFinsight
Home
Blog
About
Cash and cash
equivalents
$79,753K
(-21.43%↓ Y/Y)
Accounts receivable, net
of allowance for...
$11,386K
(18.43%↑ Y/Y)
Inventory, net
$5,695K
(-8.35%↓ Y/Y)
Prepaid expenses and
other current assets
$4,606K
(119.02%↑ Y/Y)
Property and equipment,
gross
$4,161K
(11.23%↑ Y/Y)
Total current assets
$101,440K
(-15.06%↓ Y/Y)
Property and equipment,
net
$1,667K
(14.18%↑ Y/Y)
Operating lease
right-of-use assets
$1,185K
(70.75%↑ Y/Y)
Other noncurrent
assets
$580K
(50.26%↑ Y/Y)
Less accumulated
depreciation
$2,494K
(9.34%↑ Y/Y)
Total assets
$104,872K
(-14.02%↓ Y/Y)
Total liabilities and
stockholders' equity
$104,872K
(-14.02%↓ Y/Y)
Total stockholders'
equity
$52,894K
(-24.45%↓ Y/Y)
Total liabilities
$51,978K
(0.04%↑ Y/Y)
Accumulated deficit
-$402,149K
(-7.99%↓ Y/Y)
Additional
paid-in-capital
$454,988K
(2.86%↑ Y/Y)
Long-term debt, net
$30,645K
(-23.04%↓ Y/Y)
Total current
liabilities
$20,499K
(71.74%↑ Y/Y)
Other noncurrent
liabilities
$834K
(312.87%↑ Y/Y)
Common stock, par value
0.001 per share...
$55K
(5.77%↑ Y/Y)
Short-term debt, net
$10,131K
Accrued compensation
$4,665K
(-10.75%↓ Y/Y)
Accrued and other
current liabilities
$3,805K
(-17.87%↓ Y/Y)
Accounts payable
$1,898K
(-8.57%↓ Y/Y)
Back
Back
Balance Sheet
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)
source: myfinsight.com